Nutraceutical Reports Fourth Quarter and Year End Results PARK
CITY, Utah, Nov. 25 /PRNewswire-FirstCall/ -- Nutraceutical
International Corporation today reported results for the fourth
quarter and year ended September 30, 2003. Net sales for the fiscal
2003 fourth quarter were $35.3 million compared to $29.3 million
for the same quarter of fiscal 2002. For the fourth quarter, net
income was $3.3 million, or $0.29 diluted earnings per share,
compared to $2.8 million, or $0.25 diluted earnings per share, for
the same quarter of fiscal 2002. The fiscal 2002 fourth quarter
results included $0.2 million, or $0.02 diluted earnings per share,
for payments received as partial settlement of price-fixing
litigation to which the Company was a plaintiff. Net sales for the
fiscal year ended September 30, 2003 were $124.5 million compared
to $110.9 million for fiscal 2002. For fiscal 2003, income before
change in accounting principle was $12.7 million, or $1.09 diluted
earnings per share, compared to $12.4 million, or $1.09 diluted
earnings per share, for fiscal 2002. The fiscal 2002 results
included $1.8 million, or $0.16 per share diluted, for payments
received as settlement of price-fixing litigation to which the
Company was a plaintiff. During fiscal 2003, the Company
strengthened its balance sheet, generated EBITDA of $25.0 million,
reduced debt by $2.0 million and completed the acquisitions of
Nature's Life and Arizona Health Foods for an aggregate purchase
price of $15.0 million. Bill Gay, chairman and chief executive
officer, commented, "We are pleased with our net sales and income
growth for fiscal 2003 and the most recent quarter. Nutraceutical
was formed in 1993 to effect a consolidation strategy in the
fragmented nutritional supplements industry. Ten years later, we
believe that our Company has become one of the largest
manufacturers and suppliers of branded nutritional supplements and
other natural products to and through health and natural food
stores. We have focused and will continue to focus on new product
development, synergistic acquisitions, internal growth, cost
management and creating shareholder value. We wish to express our
sincere appreciation to all of our consumers, customers, employees,
financial partners, stockholders, bankers, friends and family who
have contributed to our success over these years. We remain
positive about our business strategy and look forward to the
opportunities and challenges that lie ahead as we begin our next
decade." The Company is an integrated marketer, distributor,
retailer and manufacturer of branded nutritional supplements and
other natural products sold primarily to and through domestic
health and natural food stores. Internationally, the Company sells
its branded products to and through natural product distributors
and stores. The Company was formed with a core business strategy of
acquiring, integrating and operating, from beginning to end, the
marketing, distribution, retailing and manufacturing operations of
businesses in the natural products industry. The Company believes
that the consolidation and integration of acquired businesses
provides ongoing financial synergies through increased scale and
market penetration. The Company sells its branded products under
the trademarks Solaray(R), KAL(R), Nature's Life(R), NaturalMax(R),
VegLife(R), Premier One(R), Sunny Green(R), Natural Sport(R),
ActiPet(R), Action Labs(R), Thompson(R) and FunFresh Foods(TM). The
Company also sells branded bulk products and unbranded custom
blends under the trademarks Monarch Nutritional Laboratories(TM)
and Great Basin Botanicals(TM). Under the name Woodland
Publishing(TM), the Company publishes, prints and markets a line of
books and booklets to, among others, book distributors, national
retail bookstores and health and natural food stores. The Company's
neighborhood natural food markets operate under the trade names The
Real Food Company(TM) and Thom's Natural Foods(TM) and its health
food stores operate under the trade name Arizona Health Foods(TM).
The Company also distributes the branded products of certain third
parties. The Company manufactures and/or distributes one of the
broadest branded product lines in the industry with over 3,000
SKUs, including over 600 SKUs exclusively sold internationally. The
Company believes that as a result of its emphasis on innovation,
quality, loyalty, education and customer service, the Company's
brands are widely recognized in health and natural food stores and
among their customers. The Securities and Exchange Commission
("SEC") encourages companies to disclose forward-looking
information so that investors can better understand a company's
future prospects and make informed investment decisions. Any
statements contained herein that are not statements of historical
fact may be deemed to be forward-looking statements. Without
limitation, the words "may," "will," "should," "believes,"
"anticipates," "plans," "expects," "intends," "estimates" and
similar expressions or the negative thereof, or variations thereon,
or similarly, discussions of strategy, although believed to be
reasonable, are intended to identify forward-looking statements,
although not all forward-looking statements contain these words or
discussions. There are a number of important factors that could
cause actual events or Nutraceutical's actual results to differ
materially from those indicated by such forward-looking statements,
including, without limitation, (i) changing domestic and
international market and political conditions; (ii) interruption of
business or negative impact on sales and earnings due to acts of
war, terrorism, bio-terrorism, civil unrest or disruption of mail
service; (iii) changes in laws and regulations, including adverse
federal, state or foreign legislation or regulation or adverse
determinations or actions by regulators; (iv) import/export
controls with respect to products sold into or purchased from
foreign countries, as well as other restrictions on the purchase or
sale of Nutraceutical's products to or from such countries; (v)
unavailability of or interruption in the supply of utilities,
including electricity and telecommunications; (vi) slow or negative
growth in the nutritional supplement industry; (vii) increased
product competition; (viii) adverse publicity regarding nutritional
supplements; (ix) increased costs, including raw material and labor
costs, as well as increases in the costs of borrowing (or the
unavailability of adequate credit); (x) inability of Nutraceutical
to gain and/or hold market share of its health and natural food
store customers and bulk branded products customers; (xi) loss or
retirement of key members of management; (xii) inability of
Nutraceutical to successfully implement its business strategy or
plan or otherwise manage growth, including Nutraceutical's ability
to locate and consummate advantageous acquisitions, or otherwise
integrate or profitably manage acquired operations, including the
ability to retain customers of existing and acquired operations;
(xiii) product development efforts and consumer acceptance of
Nutraceutical's products; (xiv) absence of clinical trials for many
of Nutraceutical's products; (xv) availability and price of raw
materials, including increased costs; (xvi) Nutraceutical's ability
to manufacture its products efficiently; (xvii) the mix of
Nutraceutical's products and their related profit margins; (xviii)
dependence on distributors and customers; (xix) sales and earnings
volatility; (xx) adequacy and availability of insurance coverage,
and any losses or damages sustained by Nutraceutical not covered by
insurance; (xxi) exposure to and expense of prosecuting, defending
and/or resolving and defending claims or litigation, including but
not limited to product liability claims, class action suits,
stockholder derivative suits, employment or labor related suits or
investigations, patent or trademark infringement suits and other
litigation which may arise from time to time; (xxii) other factors
discussed in Nutraceutical's filings with the Securities and
Exchange Commission or referenced in its press releases, and
(xxiii) other factors beyond Nutraceutical's control. In addition,
any forward-looking statements represent Nutraceutical's estimates
only as of the day of this press release and should not be relied
upon as representing Nutraceutical's estimates as of any subsequent
date. No assurance can be given that the future results covered by
such forward-looking statements will be achieved and readers are
cautioned not to place undue reliance on forward-looking statements
or historical results of Nutraceutical. While Nutraceutical may
elect to update forward-looking statements at some point in the
future, Nutraceutical specifically disclaims any obligation to do
so. For further details and a discussion of these risks and
uncertainties, see Nutraceutical's SEC filings, which are updated
from time to time, copies of which are available upon request from
Nutraceutical at 435-655-6106. (C) 2003. All rights reserved.
NUTRACEUTICAL INTERNATIONAL CORPORATION CONDENSED CONSOLIDATED
BALANCE SHEETS (unaudited; dollars in thousands) September 30,
September 30, 2003 2002 Assets Current assets, net $35,994 $30,703
Property, plant and equipment, net 21,148 21,263 Goodwill 10,083
2,310 Other non-current assets, net 14,558 13,276 $81,783 $67,552
Liabilities and Stockholders' Equity Current liabilities $13,731
$10,245 Long-term liabilities 12,950 14,500 Stockholders' equity
55,102 42,807 $81,783 $67,552 NUTRACEUTICAL INTERNATIONAL
CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited; dollars in thousands, except per share data) Three
months ended Twelve months ended September 30, September 30, 2003
2002 2003 2002 Net sales $35,336 $29,294 $124,513 $110,888 Cost of
sales 17,439 14,398 60,407 53,971 Gross profit 17,897 14,896 64,106
56,917 Operating expenses Selling, general and administrative
12,279 10,033 42,916 38,224 Amortization of intangible assets 94 --
133 -- Income from operations 5,524 4,863 21,057 18,693 Interest
and other (income)/expense, net 170 333 627 (1,106) Income before
provision for income taxes 5,354 4,530 20,430 19,799 Provision for
income taxes 2,034 1,699 7,763 7,425 Income before change in
accounting principle 3,320 2,831 12,667 12,374 Cumulative effect of
change in accounting principle, net of tax benefit of $16,454,
related to adoption of goodwill impairment standard -- -- --
(35,311) Net income (loss) $3,320 $2,831 $12,667 $(22,937) Income
before change in accounting principle per common share Basic $0.30
$0.25 $1.13 $1.11 Diluted 0.29 0.25 1.09 1.09 Cumulative effect of
change in accounting principle per common share Basic $-- $-- $--
$(3.18) Diluted -- -- -- (3.12) Net income (loss) per common share
Basic $0.30 $0.25 $1.13 $(2.07) Diluted 0.29 0.25 1.09 (2.03)
Weighted average common shares outstanding Basic 11,182,765
11,162,468 11,179,964 11,111,993 Diluted 11,605,111 11,490,482
11,586,344 11,329,026 NUTRACEUTICAL INTERNATIONAL CORPORATION
EBITDA SCHEDULE (unaudited; dollars in thousands) Three months
Twelve months ended September 30, ended September 30, 2003 2002
2003 2002 Income before change in accounting principle $3,320
$2,831 $12,667 $12,374 Provision for income taxes 2,034 1,699 7,763
7,425 Interest and other (income)/expense, net (1) 170 333 627
(1,106) Depreciation and amortization (2) 1,053 971 3,941 4,168
EBITDA $6,577 $5,834 $24,998 $22,861 (1) EBITDA includes an
add-back for amortization of deferred financing fees and, for the
three months and twelve months ended September 30, 2002, EBITDA
excludes other income of $322 and $2,896, respectively, for
payments received in settlement of price-fixing litigation to which
the Company was a plaintiff. (2) EBITDA includes an add-back for
non-recurring amortization of inventory write-up for the twelve
months ended September 30, 2002 of $63. DATASOURCE: Nutraceutical
International Corporation CONTACT: Les Brown, Senior Vice
President, Finance and Chief Financial Officer of Nutraceutical
International Corporation, +1-435-655-6106
Copyright
Nutraceutical International Corp. (MM) (NASDAQ:NUTR)
Historical Stock Chart
From May 2024 to Jun 2024
Nutraceutical International Corp. (MM) (NASDAQ:NUTR)
Historical Stock Chart
From Jun 2023 to Jun 2024